These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7642769)

  • 1. Role of ultrasound in managing neuroblastoma detected by mass screening: a proposed ultrasonographic grading for children with neuroblastoma.
    Hirata T; Tatara H; Zaizen Y; Suita S; Matsuzaki A; Ueda K
    J Clin Ultrasound; 1995 Jun; 23(5):305-13. PubMed ID: 7642769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
    Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
    Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study.
    Oue T; Inoue M; Yoneda A; Kubota A; Okuyama H; Kawahara H; Nishikawa M; Nakayama M; Kawa K
    J Pediatr Surg; 2005 Feb; 40(2):359-63. PubMed ID: 15750929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
    Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
    J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Yamashiro K; Takasugi N; Hanai J; Kawai T
    Eur J Pediatr; 1990 Sep; 149(12):859-61. PubMed ID: 2226572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of mass screening for neuroblastoma in Sapporo, Japan.
    Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
    Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass screening for neuroblastoma in Japan.
    Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
    Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
    Nishi M; Miyake H; Takeda T; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hirama T; Ishikawa Y; Kudoh T; Azuma H; Takase A
    Oncol Rep; 1998; 5(3):631-3. PubMed ID: 9538165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presumed iris metastasis from abdominal neuroblastoma.
    Sekimoto M; Hayasaka S; Setogawa T; Kishi K
    Ophthalmologica; 1991; 203(1):8-11. PubMed ID: 1766642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of neuroblastoma in patients identified by mass screening using urinary catecholamine metabolites.
    Tanabe M; Yoshida H; Ohnuma N; Iwai J; Takahashi H
    J Pediatr Surg; 1993 Apr; 28(4):617-21. PubMed ID: 8483079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1987 Sep; 17(3):221-8. PubMed ID: 3669365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple liquid-chromatographic measurement of vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants.
    Hanai J; Kawai T; Sato Y; Takasugi N; Nishi M; Takeda T
    Clin Chem; 1987 Nov; 33(11):2043-6. PubMed ID: 3677377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass screening for neuroblastoma in Miyagi Prefecture.
    Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
    Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
    Suita S
    J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
    Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
    Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma.
    Groncy P; Finklestein JZ
    Pediatr Ann; 1978 Aug; 7(8):548-59. PubMed ID: 693075
    [No Abstract]   [Full Text] [Related]  

  • 20. A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Yonemori H; Hanai J; Kikuchi Y; Takasugi N
    Jpn J Clin Oncol; 1994 Oct; 24(5):247-51. PubMed ID: 7967103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.